Search Results for keywords:"Transparency"

The Health and Human Services Department, specifically through the Strategic Preparedness and Response Administration, issued a notice regarding a correction to a previous document. In the Federal Register notice 2024-28740, published on December 6, 2024, a correction was made to a figure on page 97015. This correction was officially filed on December 20, 2024.

The Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry have announced a closed meeting. Marilyn Ridenour is the contact person for any further information regarding the meeting, and she can be reached at the CDC's National Institute for Occupational Safety and Health. Kalwant Smagh, serving as the Director of the Strategic Business Initiatives Unit, is authorized to sign Federal Register notices related to meetings and other management activities for these agencies.

The U.S. Small Business Administration (SBA) published a notice in the Federal Register about the issuance of licenses for Small Business Investment Companies (SBICs). These licenses are granted under the authority of the Small Business Investment Act of 1958, which has been amended over time. The notice, effective August 17, 2023, fulfills a legal requirement to publicly list the names of the SBICs, along with their licensure date and total intended leverage commitments. This information provides transparency about the companies that received support through this program.

The memorandum from January 27, 2021, outlines President Biden's commitment to restoring trust in government through scientific integrity and evidence-based policymaking. It directs federal agencies to ensure that their scientific and technological processes are free from improper political interference and are based on sound scientific and technological methods. Agencies must update their scientific integrity policies, designate chief science officers, and establish practices that promote diversity and transparency in scientific advisory committees. Additionally, it emphasizes making federal data open and accessible for research to support informed and equitable policy decisions.

The Executive Order titled "Protecting America's Bank Account Against Fraud, Waste, and Abuse" aims to improve financial integrity within the federal government. It instructs the Department of the Treasury to enhance systems and guidance for verifying government payments to prevent fraud and improper payments. The order mandates federal agencies to consolidate their financial management systems and work with the Treasury to ensure funds are properly managed. Additionally, it focuses on increasing the transparency and efficiency of financial transactions to safeguard taxpayer dollars.

The executive order titled "Transparency Regarding Foreign Influence at American Universities" aims to increase transparency of foreign funding in U.S. educational institutions. It highlights previous failures to disclose significant foreign gifts and mandates the Department of Education to ensure universities report all foreign funding, detailing its sources and purposes. The order also facilitates public access to this information and ensures non-compliant institutions do not receive federal grants. It seeks to protect U.S. educational and national security interests by preventing secretive foreign influence.

The U.S. Office of Government Ethics (OGE) is starting to create its Strategic Plan for 2026-2030 and is seeking early input from the public. There will be a virtual public meeting on April 3, 2025, from 10 a.m. to 12 p.m. Eastern time. The OGE is asking for ideas on how it can build public trust, raise awareness about its role, and prioritize its work despite having only about 75 employees and limited resources. People can register for the meeting online and submit written comments by April 3, 2025.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting to review grant applications for the NIAID New Innovators Awards. The meeting will take place virtually on March 2-3, 2021, from 10:00 a.m. to 6:00 p.m. The discussions will include sensitive information, such as trade secrets and personal data, which is why the meeting is not open to the public. Jennifer H. Meyers, a Scientific Review Officer, can be contacted for more information.